Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions

Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions

NCT00775580 ·Status: COMPLETED ·Phase: NA

A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects

NCT03796013 ·Status: COMPLETED ·Phase: PHASE1

A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants.

NCT04111614 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions

NCT00653055 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions

NCT06600282 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body

NCT06393127 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib

NCT01645085 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy Subjects

NCT06360445 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fasted Conditions

NCT00894088 ·Status: COMPLETED ·Phase: NA

A Study of Lanabecestat (LY3314814) in Healthy Participants

NCT02663128 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalency Study of Ensartinib Capsules in Healthy Volunteers

NCT03536481 ·Status: COMPLETED ·Phase: PHASE1

A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy Volunteers

NCT02074553 ·Status: COMPLETED ·Phase: PHASE1

Phase1, Single Dose, Crossover Study to Determine Bioequivalence

NCT00786240 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions

NCT01659905 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Investigate Bioequivalence of Alpelisib Granule and Film-coated Tablet Formulation and the Food Effect of Alpelisib Granule Formulation in Adult Healthy Volunteers

NCT05195892 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet

NCT00917644 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects

NCT07126249 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted Conditions

NCT00893542 ·Status: COMPLETED ·Phase: NA

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

NCT00652873 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants

NCT02230046 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed Conditions

NCT00893958 ·Status: COMPLETED ·Phase: NA

Bioequivalence Study of Tacrolimus in Healthy Volunteers

NCT04725682 ·Status: COMPLETED ·Phase: PHASE1

A Study To Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market Product

NCT01906125 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants

NCT04277624 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalency Study of Protriptyline 10 mg Tablets Under Fasted Conditions

NCT00754962 ·Status: COMPLETED ·Phase: NA